Sopharma AD-Sofia (XBUL:SFA) EBIT per Share : лв0.91 (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia EBIT per Share?

Sopharma AD-Sofia's EBIT per Share for the three months ended in Dec. 2023 was лв0.14. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was лв0.91.

During the past 12 months, the average EBIT per Share Growth Rate of Sopharma AD-Sofia was -0.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was 16.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 13.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Sopharma AD-Sofia's EBIT per Share or its related term are showing as below:

XBUL:SFA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -9.3 Med: 2.8 Max: 16.1
Current: 16.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sopharma AD-Sofia was 16.10% per year. The lowest was -9.30% per year. And the median was 2.80% per year.

XBUL:SFA's 3-Year EBIT Growth Rate is ranked better than
69.14% of 81 companies
in the Medical Distribution industry
Industry Median: 6.9 vs XBUL:SFA: 16.10

Sopharma AD-Sofia's EBIT for the three months ended in Dec. 2023 was лв24 Mil.

Sopharma AD-Sofia EBIT per Share Historical Data

The historical data trend for Sopharma AD-Sofia's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia EBIT per Share Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.79

0.35

0.86

0.73

0.87

Sopharma AD-Sofia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.06	0.32	0.31	0.14	0.14

Sopharma AD-Sofia EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Sopharma AD-Sofia's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	121.411	/	139.097
=	0.87

Sopharma AD-Sofia's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	24.065	/	167.683
=	0.14

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.91

Sopharma AD-Sofia (XBUL:SFA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Sopharma AD-Sofia EBIT per Share Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia (XBUL:SFA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

SPH:Poland

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines